USD 0.02
(-1.96%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -210.04 Thousand USD | 66.36% |
2022 | 929.18 Thousand USD | -51.16% |
2021 | -467.65 Thousand USD | 64.72% |
2020 | -458.17 Thousand USD | 50.29% |
2019 | -2.51 Million USD | -9.72% |
2018 | -2.36 Million USD | 50.18% |
2017 | -4.72 Million USD | -6.2% |
2016 | -4.24 Million USD | 13.3% |
2015 | -5.13 Million USD | 0.4% |
2014 | -5.12 Million USD | -2.48% |
2013 | -5.3 Million USD | 44.17% |
2012 | -8.96 Million USD | -21.32% |
2011 | -10.37 Million USD | 38.79% |
2010 | -12.04 Million USD | -250.78% |
2009 | -3.37 Million USD | -10.92% |
2008 | -1.87 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -162.19 Thousand USD | 82.54% |
2024 Q2 | -250.78 Thousand USD | -59.08% |
2023 Q4 | -865.36 Thousand USD | -1619.05% |
2023 Q2 | 924.61 Thousand USD | 373.03% |
2023 Q1 | -338.64 Thousand USD | -121.8% |
2023 Q3 | 56.96 Thousand USD | -93.84% |
2023 FY | - USD | 66.36% |
2022 Q1 | -161.76 Thousand USD | 73.06% |
2022 FY | - USD | -51.16% |
2022 Q4 | 1.55 Million USD | 870.87% |
2022 Q3 | -201.51 Thousand USD | 47.21% |
2022 Q2 | -381.75 Thousand USD | -136.0% |
2021 Q4 | -600.52 Thousand USD | -282.66% |
2021 FY | - USD | 64.72% |
2021 Q3 | 328.77 Thousand USD | 157.86% |
2021 Q1 | 389.41 Thousand USD | -7.49% |
2021 Q2 | -568.17 Thousand USD | -245.91% |
2020 Q3 | -491.34 Thousand USD | -144.28% |
2020 FY | - USD | 50.29% |
2020 Q1 | -218.38 Thousand USD | 86.63% |
2020 Q4 | 420.94 Thousand USD | 185.67% |
2020 Q2 | -201.14 Thousand USD | 7.89% |
2019 Q1 | -374.47 Thousand USD | 27.22% |
2019 FY | - USD | -9.72% |
2019 Q2 | -343.87 Thousand USD | 8.17% |
2019 Q3 | -216.45 Thousand USD | 37.06% |
2019 Q4 | -1.63 Million USD | -654.87% |
2018 FY | - USD | 50.18% |
2018 Q1 | -761.57 Thousand USD | 25.84% |
2018 Q4 | -514.54 Thousand USD | -9.77% |
2018 Q3 | -468.73 Thousand USD | 21.39% |
2018 Q2 | -596.26 Thousand USD | 21.71% |
2017 Q4 | -1.02 Million USD | 18.14% |
2017 FY | - USD | -6.2% |
2017 Q3 | -1.25 Million USD | -14.59% |
2017 Q2 | -1.09 Million USD | 17.91% |
2017 Q1 | -1.33 Million USD | -15.83% |
2016 Q3 | -1.11 Million USD | -12.09% |
2016 Q4 | -1.15 Million USD | -3.66% |
2016 Q2 | -990.93 Thousand USD | 15.81% |
2016 FY | - USD | 13.3% |
2016 Q1 | -1.17 Million USD | 15.05% |
2015 Q2 | -1.49 Million USD | -37.67% |
2015 FY | - USD | 0.4% |
2015 Q4 | -1.38 Million USD | -22.73% |
2015 Q1 | -1.08 Million USD | 27.01% |
2015 Q3 | -1.12 Million USD | 24.73% |
2014 Q4 | -1.49 Million USD | -27.87% |
2014 Q3 | -1.16 Million USD | 10.51% |
2014 Q2 | -1.3 Million USD | -12.46% |
2014 FY | - USD | -2.48% |
2014 Q1 | -1.15 Million USD | -20.92% |
2013 Q2 | -1.21 Million USD | 31.87% |
2013 Q3 | -1.04 Million USD | 14.19% |
2013 Q4 | -959.24 Thousand USD | 8.01% |
2013 FY | - USD | 44.17% |
2013 Q1 | -1.78 Million USD | 35.55% |
2012 Q2 | -1.98 Million USD | 17.04% |
2012 Q1 | -2.38 Million USD | -155.92% |
2012 Q4 | -2.76 Million USD | -64.27% |
2012 FY | - USD | -21.32% |
2012 Q3 | -1.68 Million USD | 14.93% |
2011 FY | - USD | 38.79% |
2011 Q1 | -995.72 Thousand USD | 93.42% |
2011 Q2 | -13.96 Million USD | -1302.83% |
2011 Q3 | 3.31 Million USD | 123.72% |
2011 Q4 | 4.26 Million USD | 28.82% |
2010 FY | - USD | -250.78% |
2010 Q2 | -4.58 Million USD | -280.07% |
2010 Q4 | -15.12 Million USD | -450.91% |
2010 Q3 | 4.3 Million USD | 194.08% |
2010 Q1 | -1.2 Million USD | 35.62% |
2009 Q4 | -1.87 Million USD | -39.31% |
2009 Q3 | -1.34 Million USD | 0.0% |
2009 FY | - USD | -10.92% |
2008 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Achiko AG | -8.32 Million USD | 97.477% |
Accelera Innovations, Inc | - USD | Infinity% |
Aspyra Inc. | -2.84 Million USD | 92.621% |
Cannabis Sativa, Inc. | -1.11 Million USD | 81.154% |
CompuMed, Inc. | 690.19 Thousand USD | 130.432% |
CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 100.099% |
Cogstate Limited | 9.89 Million USD | 102.123% |
Craneware plc | 54.26 Million USD | 100.387% |
Caduceus Software Systems Corp. | -12.29 Million USD | 98.291% |
Certive Solutions Inc. | -704.66 Thousand USD | 70.193% |
Drug Free Solution, Inc. | -1.39 Million USD | 84.943% |
DATATRAK International, Inc. | 2.72 Million USD | 107.698% |
Strainsforpains, Inc. | -65.61 Thousand USD | -220.136% |
Healixa Inc. | -6.32 Million USD | 96.677% |
Easy Technologies Inc. | - USD | Infinity% |
eWellness Healthcare Corporation | - USD | Infinity% |
Founders Bay Holdings | 10.16 Million USD | 102.066% |
Health Discovery Corporation | - USD | Infinity% |
Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | 50.635% |
H-Source Holdings Ltd. | - USD | Infinity% |
InterCare DX, Inc. | - USD | Infinity% |
IQ-AI Limited | -370.35 Thousand USD | 43.286% |
Cannabiz Mobile, Inc. | -750.00 USD | -27905.467% |
Mednow Inc. | -28.12 Million USD | 99.253% |
Galileo Life Sciences, Inc. | -270.72 Thousand USD | 22.415% |
MediXall Group, Inc. | -6.52 Million USD | 96.78% |
Mitesco, Inc. | -11.96 Million USD | 98.244% |
MobileSmith, Inc. | -13.83 Million USD | 98.482% |
NantHealth, Inc. | -38.53 Million USD | 99.455% |
Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 87.63% |
OneLife Technologies Corp. | - USD | Infinity% |
ORHub, Inc. | -12.08 Million USD | 98.262% |
Patient Access Solutions, Inc. | -12.09 Million USD | 98.264% |
Pharma-Bio Serv, Inc. | 1.31 Million USD | 116.012% |
PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 381.067% |
Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | -1623.908% |
Renalytix Plc | -28.52 Million USD | 99.264% |
Revium Recovery Inc. | -678 Thousand USD | 69.021% |
RYAH Group, Inc. | - USD | Infinity% |
Carepay Inc. | -369.00 USD | -56821.68% |
Vaso Corporation | 4.19 Million USD | 105.007% |
Vynleads, Inc. | -235.72 Thousand USD | 10.896% |